SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-12-001683
Filing Date
2012-11-14
Accepted
2012-11-14 16:02:37
Documents
10
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vsta10q09302012.htm 10-Q 1079994
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 9608
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 9460
4 EXHIBIT 32 ex32.htm EX-32 5753
  Complete submission text file 0001415889-12-001683.txt   4718813

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vsta-20120930.xml EX-101.INS 601724
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vsta-20120930.xsd EX-101.SCH 75298
7 XBRL TAXONOMY EXTENSION CALCULATION DOCUMENT vsta-20120930_cal.xml EX-101.CAL 53831
8 XBRL TAXONOMY EXTENSION DEFINITION DOCUMENT vsta-20120930_def.xml EX-101.DEF 112027
9 XBRL TAXONOMY EXTENSION LABEL DOCUMENT vsta-20120930_lab.xml EX-101.LAB 377236
10 XBRL TAXONOMY EXTENSION PRESENTATION DOCUMENT vsta-20120930_pre.xml EX-101.PRE 206043
Mailing Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080
Business Address 384 OYSTER POINT BOULEVARD, NO. 8 SOUTH SAN FRANCISCO CA 94080 650-244-9997 X224
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54014 | Film No.: 121204332
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences